Financials
- Market Capitalization 88.28 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.19
ratio cours/chiffre d'affaires
464.04
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3982 | ICCC ImmuCell Corporation - Common Stock | 9.95 USD | -0.70% | -1.09% | -11.16% | +58.19% | 90.37 M USD | ||
| 3983 | ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.11 USD | -1.51% | -6.08% | +17.70% | -38.24% | 91.44 M USD | ||
| 3998 | RLYB Rallybio Corporation - Common Stock | 16.70 USD | -0.36% | +0.60% | +3.09% | +2992.59% | 88.69 M USD | ||
| 4002 | OKYO OKYO Pharma Limited - American Depositary Shares | 1.63 USD | +5.16% | +5.84% | -4.12% | -28.19% | 85.54 M USD |